(Q43283509)

18 November 2017

GSTM4 is a microsatellite-containing EWS/FLI target involved in Ewing's sarcoma oncogenesis and therapeutic resistance (English)

1 reference

18 November 2017

1 reference

W Luo

1

1 reference

18 November 2017

K Gangwal

2

1 reference

18 November 2017

S Sankar

3

1 reference

18 November 2017

K M Boucher

4

1 reference

18 November 2017

D Thomas

5

1 reference

18 November 2017

S L Lessnick

6

1 reference

18 November 2017

language of work or name

English

0 references

publication date

31 August 2009

1 reference

18 November 2017

1 reference

18 November 2017

28

1 reference

18 November 2017

4126-4132

1 reference

18 November 2017

46

1 reference

https://scigraph.springernature.com/pub.10.1038/onc.2009.262

18 November 2017

0 references

cites work

Microsatellites are EWS/FLI response elements: genomic "junk" is EWS/FLI's treasure

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.262

A transcriptional profiling meta-analysis reveals a core EWS-FLI gene expression signature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.262

The Ewing's sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.262

Cox's Regression Model for Counting Processes: A Large Sample Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.262

A decade of tissue microarrays: progress in the discovery and validation of cancer biomarkers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.262

A comparison of the enzymatic and physicochemical properties of human glutathione transferase M4-4 and three other human Mu class enzymes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.262

Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.262

Phase II study of intermediate-dose cytarabine in patients with relapsed or refractory Ewing sarcoma: a report from the Children's Oncology Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.262

Microsatellites as EWS/FLI response elements in Ewing's sarcoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.262

Glutathione S-transferase polymorphisms and their biological consequences

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.262

Sequence-specific knockdown of EWS-FLI1 by targeted, nonviral delivery of small interfering RNA inhibits tumor growth in a murine model of metastatic Ewing's sarcoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.262

NR0B1 is required for the oncogenic phenotype mediated by EWS/FLI in Ewing's sarcoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.262

The Ewing's sarcoma oncoprotein EWS/FLI induces a p53-dependent growth arrest in primary human fibroblasts

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.262

A T2517C polymorphism in the GSTM4 gene is associated with risk of developing lung cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.262

Manipulation of oxidative stress to induce cell death in Ewing's sarcoma family of tumours

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.262

Ewing sarcoma 11;22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FLI1 for transformation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.262

The sensitivity of the Ewing's sarcoma family of tumours to fenretinide-induced cell death is increased by EWS-Fli1-dependent modulation of p38(MAPK) activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.262

EWS/FLI mediates transcriptional repression via NKX2.2 during oncogenic transformation in Ewing's sarcoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.262

EWS/FLI-1 silencing and gene profiling of Ewing cells reveal downstream oncogenic pathways and a crucial role for repression of insulin-like growth factor binding protein 3.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.262

Expression profiling of EWS/FLI identifies NKX2.2 as a critical target gene in Ewing's sarcoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.262

Signature-based small molecule screening identifies cytosine arabinoside as an EWS/FLI modulator in Ewing sarcoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.262

Caveolin-1 (CAV1) is a target of EWS/FLI-1 and a key determinant of the oncogenic phenotype and tumorigenicity of Ewing's sarcoma cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.262

31 March 2020

Identifiers

DOI

10.1038/ONC.2009.262

1 reference

Dimensions Publication ID

18 November 2017

0 references

1 reference